Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Akkermansia Muciniphilia in Combating the Metabolic Effects of Androgen Deprivation Therapy in Men With Metastatic Prostate Cancer

NCT05802121 is registered in ClinicalTrials.gov with Western University as lead sponsor.

NCT NCT05802121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05802121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Akkermansia Muciniphilia in Combating the Metabolic Effects of Androgen Deprivation Therapy in Men With Metastatic Prostate Cancer
Lead sponsor
Western University
Phase
Phase 1
Overall status
Recruiting
Start date
July 2, 2025
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone diseases, cardiovascular morbidity, diabetes, hyperlipidemias, metabolic syndrome, obesity, prostate cancer